Nov 6, 2014, 11:47am EST Send this to a friend Email address of friend (insert comma between multiple addresses): Your email address: Copy Me Add a brief note: Send Email Processing... Medifast Medifast CEO Michael MacDonald said the company has had discussions with its large shareholders. Staff reporter- Baltimore Business Journal | Inc.'s poison pill was an expensive one to swallow. The Owings Mills-based weight loss company took on $1.6 million in legal and advisory expenses related to outside investors buying up large chunks of its stock, it said Wednesday when releasing third quarter earnings. Those stock buys prompted Medifast (NYSE: MED) to to fend off any hostile...
↧